UnitedHealth Group Incorporated
UnitedHealth Group Incorporated (UNH) Financial Performance & Income Statement Overview
Access detailed quarterly and annual financial reports for UnitedHealth Group Incorporated (UNH), covering cash flow, earnings, and balance sheets.
UnitedHealth Group Incorporated (UNH) Income Statement & Financial Overview
Review UnitedHealth Group Incorporated UNH income statement with detailed quarterly and annual figures.
Metric | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 |
---|---|---|---|---|
Revenue | $109.58B | $100.81B | $99.18B | $97.86B |
Cost of Revenue | $85.80B | $79.50B | $77.79B | $76.80B |
Gross Profit | $23.77B | $21.31B | $21.39B | $21.06B |
Gross Profit Ratio | $0.22 | $0.21 | $0.22 | $0.22 |
R&D Expenses | $0.00 | $0.00 | $0.00 | $0.00 |
SG&A Expenses | $0.00 | $0.00 | $0.00 | $0.00 |
Operating Expenses | $14.65B | $13.54B | $12.68B | $13.19B |
Total Costs & Expenses | $100.46B | $93.03B | $90.47B | $89.98B |
Interest Income | $0.00 | $0.00 | $0.00 | $0.00 |
Interest Expense | $998.00M | $1.003B | $1.07B | $985.00M |
Depreciation & Amortization | $1.06B | $1.04B | $1.04B | $1.02B |
EBITDA | $10.16B | $8.84B | $9.73B | $7.67B |
EBITDA Ratio | $0.09 | $0.09 | $0.10 | $0.08 |
Operating Income | $9.12B | $7.77B | $8.71B | $7.88B |
Operating Income Ratio | $0.08 | $0.08 | $0.09 | $0.08 |
Other Income/Expenses (Net) | -$1.01B | -$982.00M | -$1.09B | -$2.21B |
Income Before Tax | $8.11B | $6.79B | $7.61B | $5.67B |
Income Before Tax Ratio | $0.07 | $0.07 | $0.08 | $0.06 |
Income Tax Expense | $1.63B | $1.007B | $1.36B | $1.24B |
Net Income | $6.29B | $5.54B | $6.05B | $4.22B |
Net Income Ratio | $0.06 | $0.05 | $0.06 | $0.04 |
EPS | $6.91 | $5.98 | $6.56 | $4.58 |
Diluted EPS | $6.85 | $5.98 | $6.51 | $4.54 |
Weighted Avg Shares Outstanding | $918.00M | $927.00M | $923.00M | $921.00M |
Weighted Avg Shares Outstanding (Diluted) | $918.00M | $927.00M | $930.00M | $928.00M |
Financial performance has remained strong, with revenue growing from $97.86B in Q2 2024 to $109.58B in Q1 2025. Gross profit continued to perform well, with margins at 22% in the latest quarter. Operating income reached $9.12B in Q1 2025, holding a steady 8% margin. While R&D and SG&A expenses fluctuated, EBITDA remained robust at $10.16B. Net income rose to $6.29B, keeping EPS at $6.91. With disciplined cost control and operational efficiency, the company supported consistent profitability, reflecting its ability to deliver stable shareholder value.
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan